162 related articles for article (PubMed ID: 38504259)
21. Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and omicron variants in tertiary hospitals of Japan.
Sakuramoto K; Wada D; Maruyama S; Muroya T; Saito F; Nakamori Y; Kuwagata Y
BMC Infect Dis; 2024 Feb; 24(1):223. PubMed ID: 38374034
[TBL] [Abstract][Full Text] [Related]
22. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
23. Remdesivir for the treatment of COVID-19.
Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
[TBL] [Abstract][Full Text] [Related]
24. Remdesivir for the treatment of COVID-19.
Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
[TBL] [Abstract][Full Text] [Related]
25. Oxygen Debt as Predictor of Mortality and Multiple Organ Dysfunction Syndrome in Severe COVID-19 Patients: A Retrospective Study.
Perez-Garzon M; Poveda-Henao C; Bastidas-Goyes A; Robayo-Amortegui H
J Intensive Care Med; 2024 Apr; 39(4):358-367. PubMed ID: 37876236
[No Abstract] [Full Text] [Related]
26. Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study.
Bracegirdle L; Jackson A; Beecham R; Burova M; Hunter E; Hamilton LG; Pandya D; Morden C; Grocott MPW; Cumpstey A; Dushianthan A;
PLoS One; 2022; 17(6):e0269471. PubMed ID: 35687543
[TBL] [Abstract][Full Text] [Related]
27. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
28. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A
J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354
[TBL] [Abstract][Full Text] [Related]
29. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
30. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
31. [Delta of neutrophil lymphocyte index and mortality in covid-19 disease].
Rosales-López SL; Fernández-Hernández JP; Hernández-González MA; Solorio-Meza SE; González-Carrillo PL; Guardado-Mendoza R
Rev Med Inst Mex Seguro Soc; 2022 Oct; 60(6):640-648. PubMed ID: 36282995
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
35. Colchicine for the treatment of COVID-19.
Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
[TBL] [Abstract][Full Text] [Related]
36. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
[TBL] [Abstract][Full Text] [Related]
37. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
38. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
40. Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome.
Alur-Gupta S; Boland MR; Dokras A;
Fertil Steril; 2023 May; 119(5):847-857. PubMed ID: 36693555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
